Corellia AI
Maxwell Hilbert is a Senior Scientist at Corellia AI, with experience in protein biochemistry, cell biology, and enzymatic assay development. They previously worked as a Scientist at Champions Oncology and as a Graduate Research Assistant at Clemson University. Maxwell also has experience as a BioPharma Manufacturing Associate at GSK, where they executed large-scale manufacturing campaigns for recombinant human proteins. As a Project Intern at MATRIC, they created a plan for natural gas product production and distribution. Maxwell holds a PhD in Chemical Engineering from Clemson University, a MEng in Chemical Engineering from the University of Maryland, and a BS in Chemical Engineering from Virginia Tech.
This person is not in any teams
Corellia AI
Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years. Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics.